Autonomix Medical enacts 1-for-21 reverse stock split effective June 24

Autonomix Medical, Inc.

Autonomix Medical, Inc.

AMIX

0.00
  • Autonomix Medical filed to implement a 1-for-21 reverse stock split, effective 12:01 a.m. ET on June 24, 2026.
  • Nasdaq trading shifts to a post-split basis on June 24 under AMIX; new CUSIP 05330T304.
  • Outstanding shares expected to drop to about 543,000 from about 11.4 million; authorized common stock remains 500 million.
  • Holders receiving fractional entitlements will be paid cash in lieu of fractional shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-021495), on June 24, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.